
    
      The prognosis information of the patients with acute variceal bleeding will be collected,
      including hemostasis rate, early rebleeding rate, mortality, complications, severity adverse
      events, economic burdens and quality of life, when terlipressin or high dose
      somatostatin/octreotide is used as salvation to patients fail to achieve initial
      hemostasis.The results may help gastroenterologists to make decisions when administering
      vasoactive medicines to those suffered from acute variceal bleeding.
    
  